Lower IGF1 levels are associated to critical patients who need erythrocyte transfusion, or respiratory support, or develop a bronchopulmonary dysplasia or a patent ductus arteriosus, i.e., situations all related to the genesis of ROP. Here, IGF1 is linked to Patent ductus arteriosus.